HIGHLIGHTS
- who: TH and collaborators from the Department of Breast Surgery, Medical University Union Hospital, Fuzhou, China, Department of General Surgery have published the article: Thrombospondin 2 is a Functional Predictive and Prognostic Biomarker for Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy, in the Journal: (JOURNAL)
- what: The study was approved by the Research Ethics Committee of Fujian Medical University Union Hospital (2022KY122) and written informed consent was obtained from each participant before inclusion in this study.
SUMMARY
Identifying subgroup patients of different risk. Triple-negative breast cancer (TNBC) represents one . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.